Insider Transactions in Q4 2020 at Heron Therapeutics, Inc. (HRTX)
Insider Transaction List (Q4 2020)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 22
2020
|
Kimberly Manhard EVP, Drug Development |
SELL
Open market or private sale
|
Direct |
10,000
-100.0%
|
$200,000
$20.0 P/Share
|
|
Dec 22
2020
|
Kimberly Manhard EVP, Drug Development |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+50.0%
|
$130,000
$13.0 P/Share
|
|
Dec 21
2020
|
Stephen Davis Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,000
+50.0%
|
-
|
|
Dec 21
2020
|
Craig A Johnson Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,000
+43.86%
|
-
|
|
Dec 21
2020
|
Waage Christian Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,000
+40.54%
|
-
|
|
Oct 30
2020
|
John Poyhonen President & CCO |
BUY
Other acquisition or disposition
|
Direct |
637
+3.28%
|
$7,007
$11.65 P/Share
|